BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29327715)

  • 1. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.
    Reinig EF; Greipp PT; Chiu A; Howard MT; Reichard KK
    Mod Pathol; 2018 May; 31(5):705-717. PubMed ID: 29327715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
    Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
    Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroleukemia: a need for a new definition.
    Park S; Picard F; Dreyfus F
    Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
    Reichard KK; Tefferi A; Abdelmagid M; Orazi A; Alexandres C; Haack J; Greipp PT
    Blood Cancer J; 2022 Nov; 12(11):147. PubMed ID: 36323674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.
    Sun J; Konoplev SN; Wang X; Cui W; Chen SS; Medeiros LJ; Lin P
    Mod Pathol; 2011 Mar; 24(3):384-9. PubMed ID: 21113141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
    Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.
    Kanagal-Shamanna R; Bueso-Ramos CE; Barkoh B; Lu G; Wang S; Garcia-Manero G; Vadhan-Raj S; Hoehn D; Medeiros LJ; Yin CC
    Cancer; 2012 Jun; 118(11):2879-88. PubMed ID: 22038701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
    Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.
    Cleven AH; Nardi V; Ok CY; Goswami M; Dal Cin P; Zheng Z; Iafrate AJ; Abdul Hamid MA; Wang SA; Hasserjian RP
    Mod Pathol; 2015 Apr; 28(4):552-63. PubMed ID: 25412846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria.
    Margolskee E; Mikita G; Rea B; Bagg A; Zuo Z; Sun Y; Goswami M; Wang SA; Oak J; Arber DA; Allen MB; George TI; Rogers HJ; Hsi E; Hasserjian RP; Orazi A
    Mod Pathol; 2018 Jun; 31(6):873-880. PubMed ID: 29403082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
    Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
    Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
    Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
    BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroid proliferations in myeloid neoplasms.
    Wang SA; Hasserjian RP
    Hum Pathol; 2012 Feb; 43(2):153-64. PubMed ID: 22154053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.
    Courville EL; Wu Y; Kourda J; Roth CG; Brockmann J; Muzikansky A; Fathi AT; de Leval L; Orazi A; Hasserjian RP
    Mod Pathol; 2013 Jun; 26(6):751-61. PubMed ID: 23307061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic dysplasia and aberrant T-cell antigen expression in acute myeloid leukaemia with complex karyotype and
    Dannheim KC; Pozdnyakova O; Dal Cin P; Weinberg OK
    J Clin Pathol; 2018 Dec; 71(12):1051-1059. PubMed ID: 30171088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and Molecular Characteristics of De Novo AML With
    Hidalgo-López JE; Kanagal-Shamanna R; Medeiros LJ; Estrov Z; Yin CC; Verstovsek S; Konoplev S; Jorgensen JL; Mohammad MM; Miranda RN; Zhao C; Lee J; Zuo Z; Bueso-Ramos CE
    J Natl Compr Canc Netw; 2017 Jun; 15(6):790-796. PubMed ID: 28596259
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome.
    Park DC; Ozkaya N; Lovitch SB
    Histopathology; 2017 Aug; 71(2):316-321. PubMed ID: 28261852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
    Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.